Acino is a Swiss-based company that offers high quality generic products in advanced drug delivery systems. Special focus is on narcotics and extended release formulations as part of our long-term strategy to expand the product portfolio within Oncology, Urology or Pain. The products are manufactured in our Swiss plants in the Basel area and packed either in Switzerland or Estonia. In individual cases, manufacture is outsourced to selected partner companies conforming to our high quality standards.
Acino has a long track record in licensing-out dossiers developed in-house to European customers, from multinationals to local players. Fully integrated services with respect to IP, market analysis, regulatory support, legal know-how and efficient supply chain can be offered to our global customers.
If required, EU batch release can be handled by our Estonian or German sites. Serialization including aggregation is possible since November 2018 on and helps tracking all our products over the globe, thus avoiding falsification of medicines for the benefit of patients.
In order to guarantee a continuous pipeline in the therapeutic areas of interest, new products are being developed together with renowned partners worldwide under the guidance and high-quality standards of Acino and will be added to our portfolio soon.
Additionally, licenses are acquired from territories outside of Europe and products adapted to European requirements with the purpose of out-licensing them to our partners.
The following products, which are either already marketed or in registration, are currently available for out-licensing:
|Active ingredient||Formulation||Dosage strength||Indication|
|Alfuzosine||Retard tablet||5 / 10 mg||Urology|
|Amlodipine||Tablet||5 / 10 mg||Cardiovascular system|
|Clopidogrel||Film tablet||75 mg||Antithrombotic agent|
|Doxazosine||Retard tablet||4 / 8 mg||Cardiovascular system|
||Retard capsule||2/4/8/16/24 mg||Analgesics|
||Capsule||2.5/5/7.5/10/15/20/25 mg||Cancer (Multiple myeloma)|
||Retard tablet||100/25; 200/50 mg||Central nervous system|
|Metoprolol Succinate||Once-daily retard tablet||23.75 / 47.5 / 95 / 190 mg||Cardiovascular system|
||Retard tablet||50/100/200 mg||Cardiovascular system|
||Retard tablet||5/2.5;10/5;20/10;40/20 mg||Analgesics|
|Oxycodone||Retard tablet||5 / 10 / 15 / 20 / 30 / 40 / 60 / 80 mg||Analgesics|
Products which are subject to patent protection are offered with respect of the prevailing patent laws. No sales, prior to the expiry date of valid patents, are foreseen to countries where patents are in force.
Acino offers fully integrated services. Whether you opt for the entire service chain or have individual needs, we provide top-quality work, something every customer can rightfully expect from us.
Our Acino Legal team supports business transactions of all kinds, including licensing agreements, supply agreements, confidentiality agreements, M&A, and more.
Our Compliance team ensures the highest standards of ethics and integrity within all the activities at Acino.
Finally, our IP team advises on Intellectual Property rights of all the pharma products worldwide.
As a Swiss company, Quality is part of our DNA and we are motivated to ensure high quality products for our patients. Acino is committed to be compliant with all the applicable laws, guidelines as per cGMPs and applicable normatives ensuring the safety, efficacy and quality of our products.
Our Acino quality standards can ensure compliance not only with Swissmedic and EU GMP standards, but also with all the international markets where we operate.
All necessary aspects associated with quality, safety and efficacy of our products are governed by a number of both corporate and local documents such as Quality Manual, Quality Directives, and Standard Operating Procedures.
Our Regulatory department has large experience in defining the regulatory strategy in Europe for new molecules and in running DCPs, MRPs or national procedures. Maintenance of the products during their lifecycle to comply with regulations is an important task for them.
Blisters with foil (PP, Aclar, childproof foils, etc.)
Our logistics facility for oral drugs in Aesch (Switzerland) is equipped with state-of-the-art packaging lines and a fully automated high bay warehouse with 8000 pallet racks.
Our two packaging facilities are located in Switzerland and Estonia and are capable to supply globally serialized and tamper proofed products to our customers.
Managing the supply chain with a large variety of pack sizes, country-specific labeling and patient information in different languages is a well-established logistics task for our experienced team. Providing these services with the accustomed indisputable quality is a matter of course for our customers and rounds off our service offering.
Our efficient Supply chain team has of many years of experience in shipping goods around the world by air, sea or land and works together with reliable forwarding agents in order to deliver goods to our customers without causing problems at customs, during transportation (i.e. through cold chain) and with the aim to secure arrival in time.
Handling transportation of narcotics and procurement of all required licences for export in close cooperation with our customers is a routine job for them for many years.
In certain countries (mainly in Germany, the Netherlands and New Zealand) health insurance companies secure their demand of pharmaceuticals through tender contracts. Acino is a strong player in this challenging business with high volumes and competitive prices.
We constantly support our valued partners as they bid in tenders. Our credo is to sit together, discuss the supply and pricing situation in order to win the tender in spite of the strong competition. Furthermore, we assist with the needed documentation and our efficient supply chain makes sure that products are available in time to fulfill the contracts with health insurance companies and to avoid penalties.